Cognitive Change is Predicted by Beta Amyloid and Subjective Belief in Decline
In this video, Dr. Lazzara discusses a new study that identified patients at greatest risk of memory loss and global loss of cognitive function.
[SCROLL DOWN FOR VIDEO]
Published in the journal Neurology,1 a
Turns out that beta amyloid burden combined with subjective cognitive decline, identified patients at greatest risk of memory loss and global loss of cognitive function.
Amyloid burden alone was not indicative of these risks.
References:
1. Vogel JW, Varga Doležalová M, La Joie R, et al.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
- This Week on NeurologyLive® — September 15, 2025
September 15th 2025
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
- Setting Realistic Expectations for Antiamyloid Therapeutics
September 11th 2025